Work

COPA Syndrome from Diagnosis to Treatment

Year: 2023

Type: review

Source: Rheumatic Disease Clinics of North America

DOI: 10.1016/j.rdc.2023.06.005

Authors: Noa Simchoni, Tiphanie P. Vogel, Anthony K. Shum

Institutions: University of California, San Francisco, Baylor College of Medicine, Texas Children's Hospital

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Thoracic Society, Pfizer, AstraZeneca, Moderna, Swedish Orphan Biovitrum, National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: Academic Rheumatology and Clinical Immunology, Defining the molecular mechanisms of COPA syndrome through computational modeling and functional studies, Defining the Role of Thymic Tolerance in the Pathogenesis of the COPA syndrome, Unraveling the molecular mechanisms of impaired central tolerance in COPA syndrome, Academic Rheumatology and Clinical Immunology

OpenAlex ID: W4384944689

FWCI: 0.545

Cites: 55

Cited by: 22

Related to: 10